Literature DB >> 1449491

Re-examination of [3H]mepyramine binding assay for histamine H1 receptor using quinine.

Y Q Liu1, Y Horio, H Mizuguchi, K Fujimoto, I Imamura, Y Abe, H Fukui.   

Abstract

[3H]Mepyramine, a potent antagonist of the histamine H1 receptor, has been widely used as a radioligand binding assay for the H1 receptor. Previously, we purified a mepyramine binding protein (MBP) from rat liver, but found that its partial amino acid sequences were very similar to those of debrisoquine 4-hydroxylase isozymes (P450 db1 and db2), which are members of the superfamily of cytochrome P450. Using cloned histamine H1 receptor cDNA, we found that [3H]mepyramine could bind only the H1 receptor and did not bind MBP in the presence of 10(-5) M quinine, an inhibitor of debrisoquine 4-hydroxylase isozymes. We developed a method to determine the contents of the H1 receptor and MBP separately using [3H]mepyramine and quinine and found that MBP is abundant in certain areas of bovine brain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1449491     DOI: 10.1016/0006-291x(92)91569-c

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Characteristics of the binding of [3H]-mepyramine to intact human U373 MG astrocytoma cells: evidence for histamine-induced H1-receptor internalisation.

Authors:  S Hishinuma; J M Young
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

2.  Endogenous expression of histamine H1 receptors functionally coupled to phosphoinositide hydrolysis in C6 glioma cells: regulation by cyclic AMP.

Authors:  M C Peakman; S J Hill
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.